🚀 VC round data is live in beta, check it out!
AdaptHealth Valuation Multiples
Discover revenue and EBITDA valuation multiples for AdaptHealth and similar public comparables like Fukuda Denshi, Alphatec Holdings, MicroPort EP, Cofoe Medical and more.
AdaptHealth Overview
About AdaptHealth
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Founded
2017
HQ
Employees
10.9K
Website
Financials (LTM)
EV
$4B
AdaptHealth Financials
AdaptHealth reported last 12-month revenue of $3B and EBITDA of $640M.
In the same LTM period, AdaptHealth generated $708M in gross profit, $640M in EBITDA, and had net loss of ($13M).
Revenue (LTM)
AdaptHealth P&L
In the most recent fiscal year, AdaptHealth reported revenue of $3B and EBITDA of $617M.
AdaptHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $708M | XXX | $609M | XXX | XXX | XXX |
| Gross Margin | 21% | XXX | 19% | XXX | XXX | XXX |
| EBITDA | $640M | XXX | $617M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | ($13M) | XXX | ($71M) | XXX | XXX | XXX |
| Net Margin | (0%) | XXX | (2%) | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AdaptHealth Stock Performance
AdaptHealth has current market cap of $2B, and enterprise value of $4B.
Market Cap Evolution
AdaptHealth's stock price is $12.66.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $2B | 0.0% | XXX | XXX | XXX | $-0.52 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAdaptHealth Valuation Multiples
AdaptHealth trades at 1.1x EV/Revenue multiple, and 5.5x EV/EBITDA.
EV / Revenue (LTM)
AdaptHealth Financial Valuation Multiples
As of April 20, 2026, AdaptHealth has market cap of $2B and EV of $4B.
Equity research analysts estimate AdaptHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AdaptHealth has a P/E ratio of (132.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 5.5x | XXX | 5.7x | XXX | XXX | XXX |
| EV/EBIT | 14.2x | XXX | 15.0x | XXX | XXX | XXX |
| EV/Gross Profit | 5.0x | XXX | 5.8x | XXX | XXX | XXX |
| P/E | (132.8x) | XXX | (24.3x) | XXX | XXX | XXX |
| EV/FCF | 17.0x | XXX | 16.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AdaptHealth Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
AdaptHealth Margins & Growth Rates
AdaptHealth's revenue in the last 12 month grew by 7%.
AdaptHealth's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
AdaptHealth's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AdaptHealth's rule of X is 37% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
AdaptHealth Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 11% | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
AdaptHealth Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AdaptHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Fukuda Denshi | XXX | XXX | XXX | XXX | XXX | XXX |
| Alphatec Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| MicroPort EP | XXX | XXX | XXX | XXX | XXX | XXX |
| Cofoe Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Inspire Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AdaptHealth M&A Activity
AdaptHealth acquired XXX companies to date.
Last acquisition by AdaptHealth was on XXXXXXXX, XXXXX. AdaptHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AdaptHealth
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAdaptHealth Investment Activity
AdaptHealth invested in XXX companies to date.
AdaptHealth made its latest investment on XXXXXXXX, XXXXX. AdaptHealth invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AdaptHealth
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AdaptHealth
| When was AdaptHealth founded? | AdaptHealth was founded in 2017. |
| Where is AdaptHealth headquartered? | AdaptHealth is headquartered in United States. |
| How many employees does AdaptHealth have? | As of today, AdaptHealth has over 10K employees. |
| Who is the CEO of AdaptHealth? | AdaptHealth's CEO is Suzanne M. Foster. |
| Is AdaptHealth publicly listed? | Yes, AdaptHealth is a public company listed on Nasdaq. |
| What is the stock symbol of AdaptHealth? | AdaptHealth trades under AHCO ticker. |
| When did AdaptHealth go public? | AdaptHealth went public in 2018. |
| Who are competitors of AdaptHealth? | AdaptHealth main competitors are Fukuda Denshi, Alphatec Holdings, MicroPort EP, Cofoe Medical. |
| What is the current market cap of AdaptHealth? | AdaptHealth's current market cap is $2B. |
| What is the current revenue of AdaptHealth? | AdaptHealth's last 12 months revenue is $3B. |
| What is the current revenue growth of AdaptHealth? | AdaptHealth revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of AdaptHealth? | Current revenue multiple of AdaptHealth is 1.1x. |
| Is AdaptHealth profitable? | Yes, AdaptHealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of AdaptHealth? | AdaptHealth's last 12 months EBITDA is $640M. |
| What is AdaptHealth's EBITDA margin? | AdaptHealth's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of AdaptHealth? | Current EBITDA multiple of AdaptHealth is 5.5x. |
| What is the current FCF of AdaptHealth? | AdaptHealth's last 12 months FCF is $207M. |
| What is AdaptHealth's FCF margin? | AdaptHealth's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of AdaptHealth? | Current FCF multiple of AdaptHealth is 17.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.